Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program
Reading Time: < 1 minute ANNOUNCEMENT NO. 258 – 28 NOVEMBER 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements
Interim report for the period January 1 – September 30, 2024
Reading Time: 5 minutes Strengthened financial position and increased production paceIn the third quarter of 2024, Cinis Fertilizer delivered its first shipload of potassium sulfate to customer Van Iperen International, who in turn resold it to growers in approximately 25 countries worldwide. After the end of
Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data
Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024
Reading Time: 5 minutes Third quarter: 1 July – 30 September June 2024 Net revenue increased by 11,7 % to 308 858 (276 583) TSEK Organic growth amounted to 1,7 % (-13,5 %) Gross margin amounted to 28,8 % (29,4 %) Adjusted EBITA amounted to
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation
Reading Time: 3 minutes Herzogenaurach, Germany: Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s
Leqembi[®] launched in South Korea
Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult
The Psychology of Online Lottery Bonuses: Insights from LottoRanker
Reading Time: 2 minutes Stockholm, Sweden – November 2024 — LottoRanker, a trusted authority in the world of online lottery, announces its latest exploration into the psychology behind online lottery bonuses and why they resonate with players. As the digital landscape of lottery gaming continues to
Live Esports Betting: Is it different from Traditional Esports?
Reading Time: 2 minutes Stockholm, Sweden, November 2024 – eSportsRanker is a leading platform for esports enthusiasts, offering insights, reviews, and expert guidance on the latest trends in esports betting. Today, eSportsRanker is exploring a new way of betting: Live Esports Betting, a dynamic way to
Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million
Reading Time: 7 minutes Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN
Nordea Bank Abp: Repurchase of own shares on 27.11.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares27.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average